Back to search
FDAFDA · Food and drugs·Recall number D-0560-2022

Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03

Published February 23, 2022 · Recall initiated: January 14, 2022

Summary

FDA records drug Class II recall D-0560-2022, published February 23, 2022 and initiated January 14, 2022. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 115776 bottles; Lot: Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if MOXIFLOXACIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MOXIFLOXACIN
Manufacturer
Aurobindo Pharma USA Inc.
Distributor
USA Nationwide
UPC
0365862840035
Lot
Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03 recalled?

Yes. FDA published recall D-0560-2022 on February 23, 2022. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MOXIFLOXACIN. UPC: 0365862840035.